Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Sean Milmo is a freelance writer based in Essex, UK.

Articles

Regulatory agencies in Europe are working to harmonize the marketing approval pathway of generic medicines.

Harmonizing Marketing Approval of Generic Drugs in Europe

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Advances in solid and liquid formulation techniques are providing more options.

New Technologies Enhance the Formulation of Highly Potent Drugs

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

NIH seeks new therapeutic products to bolster the protective properties of vaccines.

NIH Seeks to Improve Vaccine Response with New Adjuvants

Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.

FDA and NIH Win Award for IP Licensing of Meningitis Vaccine

USP expresses its support for a consensus-based global approach to the naming of biologics.

USP Supports WHO Biologics Naming Proposal

I Holland, in collaboration with the University of Nottingham and experts from the Laboratory of Biophysics and Surface Analysis, United Kingdom, recently completed a two-year tableting science anti-stick research (TSAR) project, which sought to understand why certain formulations stick to tablet tooling.

Solving Tablet-Sticking Problems with I Holland's Predictive Model

Leading global tablet tooling manufacturer, I Holland has a range of multiple tip punches and dies optimised to meet the requirements of modern tablet production.

I Holland Leading global tablet tooling manufacturer

CALIXAR and VirPath use new manufacturing techniques to create a vaccine for the pandemic flu, influenza A (H1N1), available in 2015.

CALIXAR Collaborates with VirPath to Develop H1N1 Vaccine

Texas A&M dedicates national pandemic influenza vaccine manufacturing facility.

Pandemic Vaccine Facility Dedicated in Texas

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Micronization and other processes are used to obtain optimal particle characteristics for pulmonary and oral solid-dosage delivery.